Business
Should Australia be reconsidering its rollout of the AstraZeneca vaccine? – SBS News
OPINION: Herd immunity is the endgame for the coronavirus pandemic, but the AstraZeneca vaccine won’t get us there with an efficacy level of just 62 per cent, says…
In the past fortnight, two vaccine stories made headlines around the world.
Novavax announced spectacular results for its phase 3 trial, while preliminary data suggest the AstraZeneca vaccine is ineffective against the South African variant.
These two vaccines comprise the bulk of Australias vaccine portfolio, and the results should prompt an urgent rethink of our vaccination strategy.
Australia wont reach herd immunity with the current plan.
Australias strategy
Australia has secured access to 20…
Continue Reading
